DrugPhase maps eleven stages of drug development, from discovery to loss of exclusivity: the work at each stage, the decisions that lock years before launch, the routes forward, and where AI may shorten the path. Every decision point is sourced and dated.
No sign-up. What you add stays in your browser.
◆ where decisions lock
Use it to brief a team, plan the next stage, or check what has to be settled before a decision locks. The same guide is under How to use in the map.
Eleven stages run left to right, from discovery to loss of exclusivity. Click a stage to see what happens there and what locks.
Every activity and decision opens its detail, its source and the date it was checked. ◆ marks where a decision locks.
Forks shows the routes forward at each decision point. Paths draws your timeline against published phase durations. Charts draws your programs as a pipeline chart.
Mark where your program is, and add notes and decision points. Keep them in this browser or for this visit only, and save a file to reopen them anywhere.
Each stage has a code and an order number that never change meaning, so every Scientari tool tags its content against the same list. Stage boundaries are definitions for tagging, not regulatory facts.
Most of the choices that decide price and access are set before the IND or at the end of Phase 2. Each decision point shows its source, its checked date, and whether it is still open, being decided, or likely set for your program.
Forks show the routes forward at a decision point. Paths draw a route as a line through time, where a steeper line is a faster route, against published phase-duration ranges.
Each lever shows where AI may shorten a stage and the published evidence for it. How many months a lever saves for your program is your own estimate, entered per stage in Paths.
Add your programs, notes and decision points, and hide anything you don't need. Everything you add stays in this browser and in files you save. Nothing is sent to Scientari.
DrugPhase records what happens and when. It does not predict success, score programs or rank companies.
DrugPhase runs in your browser. What you add (programs, notes, decision points, scenarios) is never sent to Scientari or anyone else, and there's nothing to sign up for.
Under Your data › Where it's kept, choose Remember in this browser on your own computer, or This visit only on a shared one. Visit-only work is forgotten when you leave, so save a file first.
Your data › Save to file downloads one small file, usually to your Downloads folder. It's plain text that holds only what you entered, never a score.
Your data › Open a saved file brings your work back, on this or any computer. It replaces what's on the map, so save first to keep both. Send the file to a colleague to share.
This page has no analytics or tracking, and sets no cookies of its own. Fonts and every other file come from this site.
Your data › Clear my data removes your work from this browser. Delete saved files as you would any other file.
Most biotechs redraw their pipeline chart every quarter: for the website, the investor deck and the filing. The Charts tab draws them from the programs you add under Your data, on the map's stage definitions, and sends the same facts along as text so nothing has to be read off a picture.
Start from a look common on biotech pipeline pages and decks, from a full filing table to a single line per program. Then change any part: bar shape, colour, grid, grouping, labels, partner and milestone columns.
Bars stop at the stage reached, Phase 1, 2 and 3 have their own columns, and combined trials sit at the lower phase with a footnote. Checks flag a "pivotal" label before Phase 3 or undisclosed programs, citing the comment letters. Conventions, not legal advice.
EDGAR accepts only JPEG and GIF images in HTML filings, so the filing pack gives you the image, an image tag with alt text, a table to place under the chart, and the program data as a file. All four come from the same list, so they can't disagree.
A chart in a filing is a flat picture. The alt text and table carry every program, target, indication and stage as text, and the SVG export holds the data inside the file for designers and other tools.
As with the map, nothing you type is sent to Scientari or anyone else. That matters for a pipeline with programs not yet announced.
Chart columns are built from DrugPhase's stage definitions and follow the suite rule that a combined trial counts at the lower phase, so a chart and the map describe a program the same way.
Try the preview. Open the Charts tab, add your programs with a target and indication, and pick a look. Tell us what your pipeline chart still needs at [email protected].
Open ChartsScope. DrugPhase covers the US, the EU and the UK: choose under Region above the map. Stage boundaries are typical, not fixed gates; real programs overlap stages and skip some. Medical devices and diagnostics are not covered.
Decision points follow DrugHelm's verification standard: a Federal Register docket, an FDA, EMA, MHRA or eCFR page, or a named published source, plus a checked date. Activities describe common practice and state no rules or deadlines. Numbers appear only as ranges from a named source.
When an item is added or corrected, the version number changes and the change is logged. Corrections and suggestions are welcome at [email protected].
Plan the next step. DrugHelm ranks FDA pathways, non-dilutive funding and investors for your program, and the AI-Native Biotech Tracker shows which companies work at each stage.
Open DrugHelm